Related Experiment Video
Updated: Dec 16, 2025

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Assessing the Impact of TAILORx on Breast Cancer Management
Abstract:
The landmark TAILORx trial has dramatically changed the way patients with estrogen receptor-positive cancer are treated. Continued analyses from the trial have further stratified clinical risk for a subset of women who are 50 years or younger, based on their OncotypeDX Breast Recurrence Score. ONCOLOGY® recently sat down with Jane L. Meisel, MD, of Emory University School of Medicine in Atlanta, Georgia, to discuss how these data from the TAILORx trial validate and inform the current and future care of patients with breast cancer.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Therapeutic Drug Monitoring: Affecting Factors
